Interleukin-5 messenger RNA expression in peripheral blood mononuclear cells from patients with bronchial asthma and

Takao Ishizuka1, Tamotsu Ishizuka, Shigenori Iwamae

  • 1First Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Japan.

Insights

Interleukin-5 (IL-5) messenger RNA (mRNA) is elevated in patients with eosinophilic disorders like asthma. Measuring IL-5 mRNA in blood cells may help predict eosinophilia activity.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • Interleukin-5 (IL-5) is implicated in allergic diseases associated with eosinophilia.
  • Eosinophilia is a condition characterized by elevated levels of eosinophils, a type of white blood cell.

Purpose of the Study:

  • To investigate the expression of Interleukin-5 (IL-5) messenger RNA (mRNA) in peripheral blood mononuclear cells (PBMC) of patients with eosinophilic conditions.
  • To assess the potential of IL-5 mRNA detection as a biomarker for eosinophilia activity.

Main Methods:

  • Peripheral blood mononuclear cells (PBMC) were isolated from patients with bronchial asthma, chronic eosinophilic pneumonia, idiopathic eosinophilia, and healthy controls.
  • Interleukin-5 (IL-5) messenger RNA (mRNA) expression was analyzed using reverse transcription-polymerase chain reaction (RT-PCR).

Main Results:

  • IL-5 mRNA was detected in PBMC from patients with asthma, chronic eosinophilic pneumonia, and idiopathic eosinophilia, but not in controls.
  • A patient with chronic eosinophilic pneumonia showed spontaneous IL-5 mRNA expression, which decreased with prednisolone treatment.
  • IL-5 mRNA levels correlated with disease activity and preceded symptom recurrence.

Conclusions:

  • Interleukin-5 (IL-5) plays a significant role in conditions characterized by eosinophilia.
  • Detection of IL-5 mRNA in PBMC via RT-PCR may serve as a valuable tool for predicting eosinophilia activity.

Related Concept Videos